Knight Therapeutics Inc KHTRF

Primary Symbol: T.GUD

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc > 57.08 % shares held In tight hands- sharecount shrinks

<< Previous

Bullboard Posts

Next >>

Post by GoldenInvestoron Oct 06, 2023 7:54pm

212 Views

Post# 35674157

57.08 % shares held In tight hands- sharecount shrinks

14.24 held by institutions

42.84% held by insiders

57.08 % shares held

also, unsure if these numbers include the buybacks/cancellations, which would just increase their relative ownership

-growing profits, growing business.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec